UK medicines watchdog finds 30 blood clot cases after AstraZeneca
vaccinations
From CNN's Ivana Kottasová and Chris Liakos in London
The UK’s medicines watchdog has identified 30 cases of rare blood clots in people who have received the AstraZeneca Covid-19 vaccine -- 25 more than previously reported.
It added that the cases were still very rare and advises the vaccine continue to be used, as the benefits outweigh the risk.
The Medicines and Healthcare products Regulatory Agency (MHRA) said it received 22 reports of cerebral venous sinus thrombosis -- a blood clot in the sinuses that drains blood from the brain -- and eight reports of other thrombosis events where the person’s blood platelet counts were low.
These were out of a total of 18.1 million doses of the vaccine given in the UK by March 24.
The MHRA said that as of March 21, there were no reports of blood clots for the Pfizer/BioNTech vaccine, though the UK has purchased significantly fewer doses of that shot.
The European Medicines Agency and the World Health Organization also said the vaccination should continue, though several other countries have either paused or limited its use, pending investigation.
On the basis of this ongoing review, the benefits of the vaccines against Covid-19 continue to outweigh any risks and you should continue to get your vaccine when invited to do so,” the MHRA said in its weekly report into vaccination.
AstraZeneca said that “patient safety remains the Company’s highest priority,” following the report Friday.
“Regulatory authorities in the UK, European Union, the World Health Organization have concluded that the benefits of using our vaccine to protect people from this deadly virus significantly outweigh the risks across all adult age groups. The benefit risk profile of the vaccine was reaffirmed in the EMA’s monthly safety update,” it said.
選擇“Disable on www.wenxuecity.com”
選擇“don't run on pages on this domain”
